Definitive Contract 75N92020C00012
Award Date
9/29/20
Potential Completion Date
9/28/22
Potential Value
$9.5M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Visby Medical, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I action contract to Visby Medical, Inc., a for-profit medical diagnostics manufacturer. The $140,000.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of a rapid, accurate point-of-care diagnostic test under SBIR Topic 075. Visby Medical has received...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
Becton, Dickinson and Company IDS Division, doing business as BD Diagnostic Systems, has been awarded a $15.8 million firm fixed price definitive contract by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations. Under this contract, BD Diagnostic Systems will deliver its BD Veritor Plus System and SARS-CoV-2 rapid detection kits to support the National Institutes of Health's efforts to combat the coronavirus COVID-19 pandemic...
This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment, was made by the U.S. Department of Veterans Affairs (VA) through Veterans Integrated Service Network (VISN) 23. The $169,000.00 Firm Fixed Price delivery order contract, which does not have a set-aside designation, is for the provision of COVID-19 tests and analyzers to support the VA's pandemic response and ongoing infectious disease testing...
The National Institutes of Health's National Heart, Lung and Blood Institute awarded Ginkgo Bioworks, Inc. a $6.57 million firm fixed price definitive contract to support the Rapid Acceleration of Diagnostics-Advanced Technology Platforms program. The goal of this program is to increase SARS-CoV-2 testing capacity and throughput by identifying existing testing platforms that can be used for COVID-19 diagnostics. Work will be performed by Ginkgo Bioworks in Boston, Massachusetts over a one year...
This is a $24,860,014.00 firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Mesa Biotech Inc. for the development of an easy-to-use, low-cost molecular-based SARS-CoV-2 test. The contract is part of the Rapid Acceleration of Diagnostics (RADx) program, which aims to accelerate the development, validation, and commercialization of innovative COVID-19 testing technologies. The contract has a performance period ending on May 4, 2024,...
The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm-fixed-price contract to Vela Diagnostics USA Inc. for the research and development of a probe-based reverse transcriptase polymerase chain reaction (RT-PCR) test for COVID-19. The contract, which was not set aside, has a potential value of $224,780 and a completion date of October 31, 2020. Vela Diagnostics USA Inc. is a global provider of integrated molecular...
The Department of Health and Human Services National Institutes of Health National Institute of Biomedical Imaging and Bioengineering awarded a $3.75 million definitive contract to Avantgen Inc. to develop a Highly Sensitive Rapid Test Kit for SARS-CoV-2 That Does Not Require a Reader under the RADX Program Technology Project #7360. Avantgen Inc. will serve as the prime contractor and perform work in San Diego, California from November 2022 through September 2023 under a firm fixed price...
This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products, is for the delivery of COVID-19 tests and analyzers to the Veterans Integrated Service Network (VISN) 23 of the Department of Veterans Affairs (VA). The contract, valued at $498,757.12, is a Firm Fixed Price Delivery Order with a period of performance through September 30, 2023. This award is part of a larger $10 million single-award Indefinite Delivery Vehicle (IDV)...
Diasorin Molecular LLC was awarded a single award, one-year indefinite delivery/indefinite quantity contract with a potential value of $311,278.87 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23. The firm fixed price delivery order is for real-time polymerase chain reaction instrumentation to support COVID-19 and influenza testing through September 20, 2021. No set-aside provisions were applied to this award made under an existing...